07:39:16Philippines

Pharvaris N.V. (PHVS)

NASDAQ

Key stats Fiscal year 2025

Income statement

Net income
-175,699,397
Operating income
-173,711,496
Earnings per share
-2.97
R&D expense
124,478,334

Growth and profitability

Return on equity
-64.77
Return on assets
-58.28

Balance sheet

Total assets
301,454,999
Total liabilities
30,180,665
Shareholders' equity
271,274,334
Cash and equivalents
291,678,888

Cash flow and ratios

Operating cash flow
-137,073,634
Free cash flow
-137,238,253

Shareholder returns

Shares outstanding
65,210,590
Book value per share
4.16
Revenue and net income
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
Leiden
Exchange
NASDAQ
Fiscal year end
12-31
Industry (SEC)
Pharmaceutical Preparations

Fiscal year end: · Source: SEC EDGAR

Pharvaris N.V. trades on NASDAQ under the ticker symbol PHVS. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis